HER2 + Breast Cancer
34 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| BN-Brachyury, Entinostat, Adotrastuzumab Emtansine and M7824 in Advanced Stage Breast Cancer (BrEAsT) (NCT04296942) | National Cancer Institute (NCI) | 2021-05-04 |
| Precise Therapy for Refractory HER2 Positive Advanced Breast Cancer (NCT05429684) | First Affiliated Hospital Xi'an Jiaotong University | 2021-01-01 |
| The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE) (NCT04585750) | PMV Pharmaceuticals, Inc | 2020-10-29 |
| A Study to Evaluate Concurrent VRP-HER2 Vaccination and Pembrolizumab for Patients With Breast Cancer (NCT03632941) | Herbert Lyerly | 2019-03-01 |
| A Phase I Study of LJM716 in Squamous Cell Carcinoma of Head and Neck, or HER2+ Breast Cancer or Gastric Cancer (NCT01598077) | Novartis Pharmaceuticals | 2012-07-01 |
| Phase 1b/2 Study of BKM120 Plus Trastuzumab in Patients With HER2-positive Breast Cancer (NCT01132664) | Novartis Pharmaceuticals | 2010-05-01 |
Track HER2 + Breast Cancer automatically
Every clearance here is in the API, with alerts when new ones post.